BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

527 related articles for article (PubMed ID: 23598979)

  • 1. CD44 integrates signaling in normal stem cell, cancer stem cell and (pre)metastatic niches.
    Williams K; Motiani K; Giridhar PV; Kasper S
    Exp Biol Med (Maywood); 2013 Mar; 238(3):324-38. PubMed ID: 23598979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target.
    Yan Y; Zuo X; Wei D
    Stem Cells Transl Med; 2015 Sep; 4(9):1033-43. PubMed ID: 26136504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of CD44s and CD44v6 on human breast cancer cell adhesion, migration, and invasion.
    Afify A; Purnell P; Nguyen L
    Exp Mol Pathol; 2009 Apr; 86(2):95-100. PubMed ID: 19167378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of CD44 variant isoforms with hyaluronic acid and the cytoskeleton in human prostate cancer cells.
    Welsh CF; Zhu D; Bourguignon LY
    J Cell Physiol; 1995 Sep; 164(3):605-12. PubMed ID: 7544357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of alternative splicing of CD44 in cancer.
    Prochazka L; Tesarik R; Turanek J
    Cell Signal; 2014 Oct; 26(10):2234-9. PubMed ID: 25025570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic potential of human adipose stem cells in a cancer stem cell-like gastric cancer cell model.
    Liu G; Neumeister M; Reichensperger J; Yang RD
    Int J Oncol; 2013 Oct; 43(4):1301-9. PubMed ID: 23900519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of the hyaluronan receptors CD44 and RHAMM in human pancreatic cancer cells.
    Abetamann V; Kern HF; Elsässer HP
    Clin Cancer Res; 1996 Sep; 2(9):1607-18. PubMed ID: 9816340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Advances in the study of stem cell niche].
    Ju XF; An TZ; Teng CB
    Sheng Li Ke Xue Jin Zhan; 2007 Jul; 38(3):213-8. PubMed ID: 17882977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular organization, structural features, and ligand binding characteristics of CD44, a highly variable cell surface glycoprotein with multiple functions.
    Bajorath J
    Proteins; 2000 May; 39(2):103-11. PubMed ID: 10737932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional effects of SDF-1α on a CD44(+) CXCR4(+) squamous cell carcinoma cell line as a model for interactions in the cancer stem cell niche.
    Faber A; Hoermann K; Stern-Straeter J; Schultz DJ; Goessler UR
    Oncol Rep; 2013 Feb; 29(2):579-84. PubMed ID: 23232503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stem cell CD44v isoforms promote intestinal cancer formation in Apc(min) mice downstream of Wnt signaling.
    Zeilstra J; Joosten SP; van Andel H; Tolg C; Berns A; Snoek M; van de Wetering M; Spaargaren M; Clevers H; Pals ST
    Oncogene; 2014 Jan; 33(5):665-70. PubMed ID: 23318432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rho-kinase (ROK) promotes CD44v(3,8-10)-ankyrin interaction and tumor cell migration in metastatic breast cancer cells.
    Bourguignon LY; Zhu H; Shao L; Zhu D; Chen YW
    Cell Motil Cytoskeleton; 1999; 43(4):269-87. PubMed ID: 10423269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer stem-like cell marker CD44 promotes bone metastases by enhancing tumorigenicity, cell motility, and hyaluronan production.
    Hiraga T; Ito S; Nakamura H
    Cancer Res; 2013 Jul; 73(13):4112-22. PubMed ID: 23633482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Correlation of stem cell niche to genesis and development of tumor stem cells].
    Wu YY; Huang Q; Dong J; Lan Q
    Ai Zheng; 2008 Jan; 27(1):109-12. PubMed ID: 18184477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyaluronan-CD44 interaction promotes oncogenic signaling, microRNA functions, chemoresistance, and radiation resistance in cancer stem cells leading to tumor progression.
    Bourguignon LY; Shiina M; Li JJ
    Adv Cancer Res; 2014; 123():255-75. PubMed ID: 25081533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intratumoral heterogeneity in the self-renewal and tumorigenic differentiation of ovarian cancer.
    Abelson S; Shamai Y; Berger L; Shouval R; Skorecki K; Tzukerman M
    Stem Cells; 2012 Mar; 30(3):415-24. PubMed ID: 22267284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD44 variant isoforms promote metastasis formation by a tumor cell-matrix cross-talk that supports adhesion and apoptosis resistance.
    Klingbeil P; Marhaba R; Jung T; Kirmse R; Ludwig T; Zöller M
    Mol Cancer Res; 2009 Feb; 7(2):168-79. PubMed ID: 19208744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Redox regulation in stem-like cancer cells by CD44 variant isoforms.
    Nagano O; Okazaki S; Saya H
    Oncogene; 2013 Oct; 32(44):5191-8. PubMed ID: 23334333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Migratory strategies of normal and malignant stem cells.
    Hess DA; Allan AL
    Methods Mol Biol; 2011; 750():25-44. PubMed ID: 21618081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of molecular functions of the tumor metastasis promoting surface molecule CD44v4-v7 using transgenic mice.
    Moll J; Sleeman J; Kondo K; Hekele A; Plug R; Sherman L; Ponta H; Herrlich P; Schmidt A; Zöller M
    Princess Takamatsu Symp; 1994; 24():142-51. PubMed ID: 8983071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.